KR20080052662A - 혈전색전증 및 관상동맥 심장 질환의 진단 방법 - Google Patents

혈전색전증 및 관상동맥 심장 질환의 진단 방법 Download PDF

Info

Publication number
KR20080052662A
KR20080052662A KR1020087008790A KR20087008790A KR20080052662A KR 20080052662 A KR20080052662 A KR 20080052662A KR 1020087008790 A KR1020087008790 A KR 1020087008790A KR 20087008790 A KR20087008790 A KR 20087008790A KR 20080052662 A KR20080052662 A KR 20080052662A
Authority
KR
South Korea
Prior art keywords
protein
coronary heart
heart disease
myocardial infarction
egln2
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020087008790A
Other languages
English (en)
Korean (ko)
Inventor
데틀레프 코치안
마티아스 헤르만
Original Assignee
사노피-아벤티스
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 사노피-아벤티스 filed Critical 사노피-아벤티스
Publication of KR20080052662A publication Critical patent/KR20080052662A/ko
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1020087008790A 2005-10-12 2006-09-30 혈전색전증 및 관상동맥 심장 질환의 진단 방법 Withdrawn KR20080052662A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005048899.4 2005-10-12
DE102005048899A DE102005048899A1 (de) 2005-10-12 2005-10-12 Verfahren zur Diagnose thromboembolischer Erkrankungen und koronarer Herzerkrankungen

Publications (1)

Publication Number Publication Date
KR20080052662A true KR20080052662A (ko) 2008-06-11

Family

ID=37684083

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020087008790A Withdrawn KR20080052662A (ko) 2005-10-12 2006-09-30 혈전색전증 및 관상동맥 심장 질환의 진단 방법

Country Status (14)

Country Link
US (1) US20090197774A1 (enExample)
EP (1) EP1937839B1 (enExample)
JP (1) JP2009511026A (enExample)
KR (1) KR20080052662A (enExample)
CN (1) CN101287846A (enExample)
AR (1) AR056125A1 (enExample)
AT (1) ATE525481T1 (enExample)
AU (1) AU2006301578B9 (enExample)
BR (1) BRPI0617341A2 (enExample)
CA (1) CA2625698A1 (enExample)
DE (1) DE102005048899A1 (enExample)
IL (1) IL190585A (enExample)
TW (1) TW200734638A (enExample)
WO (1) WO2007042165A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9924869B2 (en) 2012-07-27 2018-03-27 Samsung Electronics Co., Ltd. Method and apparatus for determining blood flow required, method and apparatus for producing blood flow image, and method and apparatus for processing myocardial perfusion image

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005048898A1 (de) * 2005-10-12 2007-04-19 Sanofi-Aventis Deutschland Gmbh EGLN2-Varianten und ihre Verwendung bei der Vorbeugung oder Behandlung thromboembolischer Erkrankungen und koronarer Herzerkrankungen
EP2311981B1 (en) 2007-05-01 2014-09-17 The Regents of The University of California Methods for diagnosing ischemia
US20120015904A1 (en) * 2010-07-14 2012-01-19 Regents Of The University Of California Biomarkers for diagnosis of transient ischemic attacks
CA2804802C (en) 2010-07-15 2023-03-07 The Regents Of The University Of California Biomarkers for diagnosis of stroke and its causes
US20120316076A1 (en) 2011-03-04 2012-12-13 The Regents Of The University Of California Biomarkers for the diagnosis of lacunar stroke
CA2856461C (en) * 2011-12-01 2020-08-18 F. Hoffmann-La Roche Ag Nt-proanp and nt-probnp for the diagnosis of stroke
WO2013103781A1 (en) 2012-01-07 2013-07-11 The Regents Of The University Of California Biomarkers for diagnosing ischemia
CN119846215B (zh) * 2025-01-22 2025-07-11 广西医科大学附属肿瘤医院 Egln1乳酸化作为靶点在制备肿瘤诊断试剂盒或治疗药物中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2474630B1 (en) * 2002-12-20 2016-04-27 Celera Corporation Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof
CA2510895A1 (en) * 2002-12-20 2004-07-15 Applera Corporation Genetic polymorphisms associated with stenosis, methods of detection and uses thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9924869B2 (en) 2012-07-27 2018-03-27 Samsung Electronics Co., Ltd. Method and apparatus for determining blood flow required, method and apparatus for producing blood flow image, and method and apparatus for processing myocardial perfusion image

Also Published As

Publication number Publication date
CN101287846A (zh) 2008-10-15
TW200734638A (en) 2007-09-16
AR056125A1 (es) 2007-09-19
IL190585A0 (en) 2008-11-03
AU2006301578B2 (en) 2011-12-01
ATE525481T1 (de) 2011-10-15
WO2007042165A1 (de) 2007-04-19
US20090197774A1 (en) 2009-08-06
AU2006301578B9 (en) 2011-12-22
AU2006301578A1 (en) 2007-04-19
EP1937839A1 (de) 2008-07-02
CA2625698A1 (en) 2007-04-19
JP2009511026A (ja) 2009-03-19
EP1937839B1 (de) 2011-09-21
DE102005048899A1 (de) 2007-04-19
IL190585A (en) 2011-12-29
BRPI0617341A2 (pt) 2011-07-26

Similar Documents

Publication Publication Date Title
US8426128B2 (en) Methods and compositions for vitamin K epoxide reductase
IL190585A (en) Method for the diagnosis of thromboembolic and coronary heart diseases
JP2003535601A (ja) ヒトチトクロムp4502a6遺伝子の遺伝子型決定と関連物質および方法
WO2004111272A2 (en) Polymorphism in the human nbs1 gene useful in diagnostic of inherited predisposition to cancer
JP3682688B2 (ja) 骨粗鬆症薬剤感受性予測方法およびそのための試薬キット
HK1125414A (en) Method for diagnosing thromboembolic disorders and coronary heart diseases
JP3684921B2 (ja) 骨粗鬆症薬剤感受性予測方法
JP4444576B2 (ja) 2型糖尿病関連遺伝子
JP4048555B2 (ja) 骨粗鬆症薬剤感受性予測方法
CN102443630A (zh) 人ppp2r3a基因突变及其用途
EP1232245A1 (en) Gene and methods for diagnosing neuropsychiatric disorders and treating such disorders
JP5111763B2 (ja) 気管支喘息の遺伝的素因検査方法
JP4845486B2 (ja) 糖尿病性腎症感受性遺伝子、および糖尿病性腎症の予防または治療剤の有効成分のスクリーニング方法
US20120004266A1 (en) Dopamine-beta-hydroxylase genetic polymorphism and migraine
Eminović et al. New steroid 5α-reductase type I (SRD5A1) homologous sequences on human chromosomes 6 and 8
US20030223986A1 (en) Methods
KR20070004804A (ko) 혈전 질환을 발병시키는 소인의 진단 방법 및 이의 용도
JP2004275101A (ja) グルココルチコイド製剤への感受性の遺伝子診断に用いることができる変異型ポリヌクレオチドおよび核酸分子
EP1264841A1 (en) DNA encoding a mutant peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1), detection methods and test kits therefor
BUTLER PPEEEDDDIIIAAATTTRRRIIICCC HHHYYYPPPEEERRRTTTEEENNNSSSIIIOOONN
WO2006073183A1 (ja) 一塩基多型を用いた炎症性疾患の判定方法
KR20060096144A (ko) HNF-4α 유전자의 단일염기 다형성 및 그 용도
JP2003219886A (ja) プロテイン1遺伝子の一塩基多型を含む核酸およびそれを用いたプロテイン1関連疾患の診断方法
JP2004305083A (ja) グルクロン酸抱合酵素1a9による薬物解毒代謝の異常の遺伝子診断に用いることができる変異型ポリヌクレオチドおよび核酸分子
JP2003052379A (ja) アレルギー疾患関連il−4遺伝子多型及びその利用方法

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20080411

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20110929

Comment text: Request for Examination of Application

PC1202 Submission of document of withdrawal before decision of registration

Comment text: [Withdrawal of Procedure relating to Patent, etc.] Withdrawal (Abandonment)

Patent event code: PC12021R01D

Patent event date: 20120105

WITB Written withdrawal of application